You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Man reading a book

Frequently asked questions

We understand starting a new treatment can come with a host of questions. We have included a few below - if you have any additional questions, we recommend talking to your cancer care team.

What is a monoclonal antibody?

A monoclonal antibody (mAb) is a protein made in a laboratory that looks and works like an antibody made by your body’s immune system. Antibodies stick to specific proteins on the surface of harmful or abnormal cells and act as a flag for the immune system to destroy them.

What is B-cell maturation antigen (BCMA)?

BCMA is a protein that is found in large amounts on the outside of myeloma cancer cells, but in lower amounts on healthy cells. This makes it a good target for BCMA-targeting drugs, like BLENREP, so that treatments can kill the cancerous multiple myeloma cells.

Why does BLENREP lead to eye-related side effects?

BLENREP can be absorbed by healthy cells in the body, including cells on the outside of the eye, called the cornea, which may lead to changes that can happen with or without symptoms.

How can I tell if my vision is blurred if I am already using prescription glasses?

During your first eye test, your eye care professional will assess your eyesight, including your glasses prescription. Tell your doctor or nurse if your vision is getting worse even when wearing glasses.

Can I continue working during treatment?

Consult your doctor or care team and consider how you may be able to adjust your work as needed, especially if you drive or operate machinery. If you have difficulty reading or seeing screens clearly, discuss these with your care team, who may be able to provide suggestions and support for you.

Can I continue taking other medications?

It is important to tell your doctor about all other medications you are taking before you start BLENREP. If you experience a side effect or another medical issue while receiving BLENREP, talk to your doctor before taking any medication, including over-the-counter medicines or natural remedies or supplements.

Can I still go on holiday during treatment?

Talk to your doctor before booking any holidays to make sure that they don’t overlap with your treatments. Your doctor might change how often you have treatments, which can change your appointment dates.

Additional Support

NA

Blood Cancer UK provides comprehensive support to patients, providing reliable digital and printed information, practical and emotional assistance via a nurse-led support line, a clinical trials support service and an online community forum to connect with others. Get in touch on 0808 2080 888 or online https://bloodcancer.org.uk/support-for you/talk-blood-cancer/

NA

Myeloma UK is the only UK charity focused on myeloma and its related conditions. They provide support and campaign for access to treatments, while researching a cure. Website: www.myeloma.org.uk/ Call our Infoline: 0800 980 3332

NA

OUTpatients is the UK’s LGBTIQ+ cancer charity. Proudly patient-led, they exist to shake up the system, advocate for equity, and stand up for every LGBTIQ+ individual navigating the cancer journey. They host peer support, educate healthcare professionals, and help to shape national policy that supports the LGBTIQ+ community. Find out more at: OUTpatients.org.uk

NA

Shine Cancer Support provides information, support and community to anyone in their 20s, 30s or 40s with cancer. They also have specific programmes for those living with ‘chronic’ or incurable cancers. https://shinecancersupport.org/

Please note that these organisations are separate to GSK.

If you experience any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the package leaflet.

You can also report side effects directly via the Yellow Card Scheme at: https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or uksafety@gsk.com.

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See information in paragraph above to see how to report side effects.

Blenrep is a registered trademark of the GlaxoSmithKline group of companies